Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Janssen Biotech
Pharma
J&J makes its case for Tremfya in two IBD indications
Tremfya's prospects in inflammatory bowel disease look bright, thanks to the drug's first efficacy data in UC and long-term results in Crohn's.
Fraiser Kansteiner
Feb 18, 2022 10:30am
J&J's Blue Jacket Fashion Show returns live
Feb 15, 2022 7:25am
For pharma sales reps dealing with HCPs, the future is digital
Dec 8, 2021 7:15am
Aspen trumpets its "game changer" licensing pact-to-be with J&J
Dec 2, 2021 9:30am
Further growth coming for J&J's manufacturing site in Ireland
Sep 13, 2021 9:28am
J&J taps Twitter to expand its network of patient storytellers
Jul 20, 2021 11:29am
